Chimeric antigen receptor (CAR‐T) cell therapy is a newly developed immunotherapy
strategy and has achieved satisfactory outcomes in the treatment of hematological …

Simple Summary Chimeric antigen receptor (CAR)-T cell therapy has exhibited good
application prospects in the treatment of hematologic malignancies. However, there are still …

The application of chimeric antigen receptor (CAR) T cells in the management of
hematological malignancies has emerged as a noteworthy therapeutic breakthrough …

Chimeric antigen receptor (CAR)-T cell therapy is an innovative approach to immune cell
therapy that works by modifying the T cells of a patient to express the CAR protein on their …

The three major standard therapies, that is, surgery, chemotherapy, and radiation therapy
have conventionally been applied to the treatments for cancers and have saved many …

For several decades, surgery, chemotherapy and radiation therapy have been the
fundamental components of cancer treatment. Although these represent key therapeutic …

Simple Summary It is well recognized now that the development of drug resistance is one of
the leading causes of treatment failure in conventional therapies. In comparison, recent …

Simple Summary Chimeric antigen receptor T cells (CAR T-cells) are engineered T cells that
target tumor-associated antigens. CAR T-cell therapy is a novel developed immunotherapy …

Immunotherapy has emerged as one of the most effective treatments capable of overcoming
tumor resistance mechanisms due to its ability to modulate the patient's immune response …

Recent reports on the impressive efficacy of chimeric antigen receptor (CAR)-modified T
cells against hematologic malignancies have inspired oncologists to extend these efforts for …